FDA Approves Stelara for Adults with Moderate-to-Severe Active Crohn’s Disease
News
Janssen Biotech recently announced that the company’s Stelara (ustekinumab) for the treatment of moderate-to-severe active Crohn’s disease in adults, has been approved by the U.S. Food and Drug Administration (FDA). Stelara is the ... Read more